US Stock MarketDetailed Quotes
BLPH Bellerophon Therapeutics
- 0.055
- 0.0000.00%
15min DelayClose Nov 21 16:00 ET
672.80KMarket Cap-61P/E (TTM)
0.000High0.000Low0Volume0.000Open0.055Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)12.23MShares0.10052wk High0.18P/B654.87KFloat Cap0.03052wk Low--Dividend TTM11.91MShs Float193.800Historical High--Div YieldTTM0.00%Amplitude0.029Historical Low--Avg Price1Lot Size
About Bellerophon Therapeutics Company
Bellerophon Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of products that address significant unmet medical needs in the treatment of cardiopulmonary diseases. Its product pipeline includes PH-ILD, PH-COPD, INOpulse and PH-Sarc. The company was founded in 2009 and is headquartered in Warren, NJ.
Company Profile
SymbolBLPH
Company NameBellerophon Therapeutics
Listing DateFeb 13, 2015
Issue Price12.00
Founded2009
CEOMr. Peter Fernandes
MarketPink Market
Employees18
Fiscal Year Ends12-31
Address184 Liberty Corner Road,Suite 302
CityWarren
ProvinceNew Jersey
CountryUnited States of America
Zip Code07059
Phone1-908-574-4770
Websitehttp://www.bellerophon.com
Company Executives
- Name
- Position
- Salary
- Bobae Kim
- Vice President, Regulatory Affairs and Quality Assurance
- --
- Naseem Amin
- Chairman of the Board
- 83.10K
- Mary Ann Cloyd
- Independent Director
- 97.40K
- Scott P. Bruder
- Independent Director
- 84.90K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data